115 related articles for article (PubMed ID: 36039881)
1. Differential expression of miRNAs related to autophagy pathway in tissue and serum samples of colorectal cancer patients.
Yilmaz U; Yilmaz N; Tanbek K; Ergen A; Aksakal N; Zeybek U
Bratisl Lek Listy; 2022; 123(9):634-640. PubMed ID: 36039881
[TBL] [Abstract][Full Text] [Related]
2. Ox-LDL-induced lncRNA MALAT1 promotes autophagy in human umbilical vein endothelial cells by sponging miR-216a-5p and regulating Beclin-1 expression.
Wang K; Yang C; Shi J; Gao T
Eur J Pharmacol; 2019 Sep; 858():172338. PubMed ID: 31029709
[TBL] [Abstract][Full Text] [Related]
3. Association of Beclin-1 and microRNA-30a expression with the severity and treatment response of colorectal cancer.
Liu L; Meng T; Wang QS; Jin HZ; Sun ZQ; Jin B; Fang F; Wang HJ
Genet Mol Res; 2016 Apr; 15(2):. PubMed ID: 27173217
[TBL] [Abstract][Full Text] [Related]
4. A panel of seven-miRNA signature in plasma as potential biomarker for colorectal cancer diagnosis.
Zhang H; Zhu M; Shan X; Zhou X; Wang T; Zhang J; Tao J; Cheng W; Chen G; Li J; Liu P; Wang Q; Zhu W
Gene; 2019 Mar; 687():246-254. PubMed ID: 30458288
[TBL] [Abstract][Full Text] [Related]
5. microRNA expression profile in stage III colorectal cancer: circulating miR-18a and miR-29a as promising biomarkers.
Brunet Vega A; Pericay C; Moya I; Ferrer A; Dotor E; Pisa A; Casalots À; Serra-Aracil X; Oliva JC; Ruiz A; Saigí E
Oncol Rep; 2013 Jul; 30(1):320-6. PubMed ID: 23673725
[TBL] [Abstract][Full Text] [Related]
6. The PVT1/miR-216b/Beclin-1 regulates cisplatin sensitivity of NSCLC cells via modulating autophagy and apoptosis.
Chen L; Han X; Hu Z; Chen L
Cancer Chemother Pharmacol; 2019 May; 83(5):921-931. PubMed ID: 30859368
[TBL] [Abstract][Full Text] [Related]
7. miR-204-5p expression in colorectal cancer: an autophagy-associated gene.
Sümbül AT; Göğebakan B; Ergün S; Yengil E; Batmacı CY; Tonyalı Ö; Yaldız M
Tumour Biol; 2014 Dec; 35(12):12713-9. PubMed ID: 25209181
[TBL] [Abstract][Full Text] [Related]
8. Circulating microRNA-1290 as a novel diagnostic and prognostic biomarker in human colorectal cancer.
Imaoka H; Toiyama Y; Fujikawa H; Hiro J; Saigusa S; Tanaka K; Inoue Y; Mohri Y; Mori T; Kato T; Toden S; Goel A; Kusunoki M
Ann Oncol; 2016 Oct; 27(10):1879-86. PubMed ID: 27502702
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of Beclin-1-Mediated Autophagy by MicroRNA-17-5p Enhanced the Radiosensitivity of Glioma Cells.
Hou W; Song L; Zhao Y; Liu Q; Zhang S
Oncol Res; 2017 Jan; 25(1):43-53. PubMed ID: 28081732
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-6869-5p acts as a tumor suppressor via targeting TLR4/NF-κB signaling pathway in colorectal cancer.
Yan S; Liu G; Jin C; Wang Z; Duan Q; Xu J; Xu D
J Cell Physiol; 2018 Sep; 233(9):6660-6668. PubMed ID: 29206292
[TBL] [Abstract][Full Text] [Related]
11. Tumor-derived exosomal miRNA-320d as a biomarker for metastatic colorectal cancer.
Tang Y; Zhao Y; Song X; Song X; Niu L; Xie L
J Clin Lab Anal; 2019 Nov; 33(9):e23004. PubMed ID: 31420913
[TBL] [Abstract][Full Text] [Related]
12. MTUS1 and its targeting miRNAs in colorectal carcinoma: significant associations.
Ozcan O; Kara M; Yumrutas O; Bozgeyik E; Bozgeyik I; Celik OI
Tumour Biol; 2016 May; 37(5):6637-45. PubMed ID: 26643896
[TBL] [Abstract][Full Text] [Related]
13. Global and targeted circulating microRNA profiling of colorectal adenoma and colorectal cancer.
Zhang J; Raju GS; Chang DW; Lin SH; Chen Z; Wu X
Cancer; 2018 Feb; 124(4):785-796. PubMed ID: 29112225
[TBL] [Abstract][Full Text] [Related]
14. miRNAs-Based Molecular Signature for
Milanesi E; Dobre M; Bucuroiu AI; Herlea V; Manuc TE; Salvi A; De Petro G; Manuc M; Becheanu G
J Immunol Res; 2020; 2020():4927120. PubMed ID: 32676506
[TBL] [Abstract][Full Text] [Related]
15. Clinical response and prognostic significance of serum miR-497 expression in colorectal cancer.
Zou G; Wang R; Wang M
Cancer Biomark; 2019; 25(1):11-18. PubMed ID: 31006664
[TBL] [Abstract][Full Text] [Related]
16. Expression Analysis of Previously Verified Fecal and Plasma Dow-regulated MicroRNAs (miR-4478, 1295-3p, 142-3p and 26a-5p), in FFPE Tissue Samples of CRC Patients.
Ghanbari R; Rezasoltani S; Hashemi J; Mohamadkhani A; Tahmasebifar A; Arefian E; Mobarra N; Asadi J; Nazemalhosseini Mojarad E; Yazdani Y; Knuutila S; Malekzadeh R
Arch Iran Med; 2017 Feb; 20(2):92-95. PubMed ID: 28193082
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of microRNA-216a inhibits autophagy by targeting regulated MAP1S in colorectal cancer.
Wang Y; Zhang S; Dang S; Fang X; Liu M
Onco Targets Ther; 2019; 12():4621-4629. PubMed ID: 31354295
[No Abstract] [Full Text] [Related]
18. The expression of microRNA-375 in plasma and tissue is matched in human colorectal cancer.
Xu L; Li M; Wang M; Yan D; Feng G; An G
BMC Cancer; 2014 Sep; 14():714. PubMed ID: 25255814
[TBL] [Abstract][Full Text] [Related]
19. Plasma microRNA-1207-5p as a Potential Biomarker for Diagnosis and Prognosis of Colorectal Cancer.
Wang X; Li L; Xiao W; Xu Q
Clin Lab; 2020 Sep; 66(9):. PubMed ID: 32902212
[TBL] [Abstract][Full Text] [Related]
20. MiR-216a-3p inhibits colorectal cancer cell proliferation through direct targeting COX-2 and ALOX5.
Wang D; Li Y; Zhang C; Li X; Yu J
J Cell Biochem; 2018 Feb; 119(2):1755-1766. PubMed ID: 28786533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]